Funded Tech Companies

Biodel

Wondering who provided funding to Biodel? Pangaea Ventures, OrbiMed and Great Point Partners joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Company Name
Biodel
Company Status
Publicly-held
Funding Rounds

Contact Information

Mailing Address
100 Saw Mill Rd.
Danbury, CT 06810
USA
Email Address

Company Background Information

Overview
Biodel Inc. is a specialty pharmaceutical company that develops novel formulations of FDA approved therapeutics to treat endocrine disorders such as diabetes. Biodel's products are created by utilizing the company's proprietary VIAdel technology.
Profile
Biodel LinkedIn Company Profile
Social Media
Biodel Company Twitter Account
Company News
Biodel News
Facebook
Biodel on Facebook
YouTube
Biodel on YouTube
Last Transaction
9/13/2023

Financing History

Date
Type
Amount
IPO
Unknown
IPO
$46,400,000
Venture Equity
$21,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Solomon Steiner
  Solomon Steiner LinkedIn Profile  Solomon Steiner Twitter Account  Solomon Steiner News  Solomon Steiner on Facebook
Chief Financial Officer
Gerard Michel
  Gerard Michel LinkedIn Profile  Gerard Michel Twitter Account  Gerard Michel News  Gerard Michel on Facebook
Chief Medical Officer
Alan Krasner
  Alan Krasner LinkedIn Profile  Alan Krasner Twitter Account  Alan Krasner News  Alan Krasner on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

BioDatomics | Biodesix

 

Share this article

 


About Our Venture Capital Transactions Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary